Acumen Pharmaceuticals Inc (ABOS)
2.31
-0.06
(-2.53%)
USD |
NASDAQ |
Nov 21, 16:00
2.305
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Enterprise Value: -33.40M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -33.40M |
| November 20, 2024 | -29.80M |
| November 19, 2024 | -28.60M |
| November 18, 2024 | -37.61M |
| November 15, 2024 | -28.00M |
| November 14, 2024 | -15.38M |
| November 13, 2024 | -20.19M |
| November 12, 2024 | -11.48M |
| November 11, 2024 | 21.27M |
| November 08, 2024 | 24.27M |
| November 07, 2024 | 18.26M |
| November 06, 2024 | 21.87M |
| November 05, 2024 | 8.050M |
| November 04, 2024 | 5.046M |
| November 01, 2024 | -1.262M |
| October 31, 2024 | 0.8408M |
| October 30, 2024 | 9.853M |
| October 29, 2024 | 2.343M |
| October 28, 2024 | 1.442M |
| October 25, 2024 | 2.042M |
| October 24, 2024 | -7.570M |
| October 23, 2024 | -10.57M |
| October 22, 2024 | -3.966M |
| October 21, 2024 | -9.974M |
| October 18, 2024 | -0.3608M |
| Date | Value |
|---|---|
| October 17, 2024 | -12.38M |
| October 16, 2024 | -28.60M |
| October 15, 2024 | -32.20M |
| October 14, 2024 | -31.00M |
| October 11, 2024 | -31.00M |
| October 10, 2024 | -37.01M |
| October 09, 2024 | -34.61M |
| October 08, 2024 | -30.40M |
| October 07, 2024 | -29.20M |
| October 04, 2024 | -29.80M |
| October 03, 2024 | -28.60M |
| October 02, 2024 | -21.99M |
| October 01, 2024 | -24.99M |
| September 30, 2024 | -23.19M |
| September 27, 2024 | -83.60M |
| September 26, 2024 | -86.61M |
| September 25, 2024 | -92.02M |
| September 24, 2024 | -86.01M |
| September 23, 2024 | -90.21M |
| September 20, 2024 | -82.40M |
| September 19, 2024 | -77.60M |
| September 18, 2024 | -86.01M |
| September 17, 2024 | -83.60M |
| September 16, 2024 | -80.00M |
| September 13, 2024 | -76.39M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-107.72M
Minimum
Nov 09 2023
742.25M
Maximum
Jul 06 2021
80.56M
Average
26.05M
Median
Oct 02 2023
Enterprise Value Benchmarks
| Kodiak Sciences Inc | 112.62M |
| NovaBay Pharmaceuticals Inc | 2.798M |
| Palatin Technologies Inc | 15.96M |
| iBio Inc | 12.31M |
| Theriva Biologics Inc | -12.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.76M |
| Total Expenses (Quarterly) | 32.26M |
| EPS Diluted (Quarterly) | -0.50 |
| Earnings Yield | -59.74% |